New Liver Cancer Treatment Shows 60% 4-Year Survival Rate
A groundbreaking immunotherapy treatment given before surgery is helping liver cancer patients beat the odds, with 60% surviving four years or more. Researchers in Taiwan discovered that priming the immune system before removing tumors creates a lasting defense against one of the deadliest cancers.